MSIV Closes $11M-Plus Fund II for North Bay Startups
Marin Sonoma Impact Ventures closed Fund II above $11 million with 60 LPs, 98% of capital from Marin and Sonoma, and nine investments already completed.
Marin Sonoma Impact Ventures closed Fund II above $11 million with 60 LPs, 98% of capital from Marin and Sonoma, and nine investments already completed.
Aphias Capital closed its inaugural healthcare and essential-services private equity fund above $1.05 billion, exceeding its $900 million target and hard cap.
Sheridan Capital Partners closed a $1.1 billion Fund IV and a separate $245 million debut healthcare IT fund. The aggregate is nearly $1.35 billion across two private-equity vehicles—not one fund.
NABVENTURES has secured ₹450 crore at the first close of Fund II, anchored by NABARD. The vehicle targets ₹1,500 crore including a greenshoe for Indian agriculture, rural fintech and climate businesses.
SEVA Growth closed its second software-focused growth-equity fund at $160 million, exceeding a $125 million target. Its concentrated minority-investment strategy creates both alignment and portfolio-concentration risk.
Arcturus Therapeutics signed a definitive agreement to acquire Belgian AI drug-discovery company myNEO. Terms are undisclosed, and closing is expected in October subject to customary conditions.